Asparagine

Asparagine

SCHEMBL30131205

N[13C](=O)[13CH2][13C@H](N)[13C](=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Asparagine SCHEMBL8826 1.00
Asparagine SCHEMBL30486685 1.00
Asparagine SCHEMBL150535 1.00 ALOX15 (0.56)
Asparagine SCHEMBL8827 1.00
Asparagine SCHEMBL288094 1.00 ALOX15 (0.56)
Asparagine SCHEMBL288093 1.00 ALOX15 (0.56)
Asparagine SCHEMBL4347082 1.00 ALOX15 (0.56)
Asparagine SCHEMBL15460 1.00 ALOX15 (0.56)
Asparagine SCHEMBL20489207 1.00 ALOX15 (0.56)
Asparagine SCHEMBL30610983 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119881145-A Liquid chromatography tandem mass spectrometry method for measuring multiple amino acids 上海市徐汇区中心医院 2025-04-25 CN disclosed
US-20240238235-A1 METHODS AND COMPOSITIONS FOR TREATING PULMONARY ALVEOLAR PROTEINOSIS RELATED TO MARS MUTATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2024-07-18 US disclosed
EP-4346792-A1 METHODS AND COMPOSITIONS FOR TREATING PULMONARY ALVEOLAR PROTEINOSIS RELATED TO MARS MUTATIONS Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2024-04-10 EP disclosed
WO-2022248542-A1 METHODS AND COMPOSITIONS FOR TREATING PULMONARY ALVEOLAR PROTEINOSIS RELATED TO MARS MUTATIONS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2022-12-01 WO disclosed